AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 8.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $3,028,000 | -15.1% | 123,550 | -17.1% | 0.62% | -21.8% |
| Q2 2016 | $3,565,000 | -0.6% | 149,050 | -2.8% | 0.80% | -6.5% |
| Q1 2016 | $3,588,000 | -6.9% | 153,325 | +20.1% | 0.85% | -6.0% |
| Q4 2015 | $3,853,000 | -41.0% | 127,625 | -22.3% | 0.91% | -40.9% |
| Q3 2015 | $6,529,000 | -71.7% | 164,325 | -50.9% | 1.53% | -39.4% |
| Q2 2015 | $23,102,000 | +229.7% | 334,520 | +160.9% | 2.53% | +76.8% |
| Q1 2015 | $7,007,000 | – | 128,200 | – | 1.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
| Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
| Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
| Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
| Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |